Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1252 of 5804
-
New CT algorithm aims to perfect heart valve sizing for tricky bicuspid patients
Disease control Recruiting nowThe goal of this study is to learn what effects the ABC Bicuspid Sizing Algorithm has on the clinical outcomes of patients with bicuspid aortic stenosis after having a transcatheter aortic valve replacement (TAVR) using the Sapien 3 valve. The main questions the study aims to ans…
Sponsor: World Health Research Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Hope for rare brain disorder: new drug trial targets Jordan's syndrome
Disease control OngoingThe primary objective of this study is to assess the efficacy, safety, and tolerability of BPN14770 in participants aged 9 to 45 years with JS.
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for PAH patients: sotatercept safety trial expands
Disease control OngoingResearchers are looking for other ways to treat pulmonary arterial hypertension (PAH). Sotatercept is a study medicine that is designed to treat PAH. A past study, MK-7962-024 (LIGHTRAY) (NCT06664801), learned about the safety and effects of sotatercept in people with PAH. One o…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), a…
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Heart plaque showdown: combo pill vs. super statin
Disease control Recruiting nowThis study is a prospective, multicenter, randomized clinical trial aimed at comparing the effects of moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy on coronary plaque stabilization. Using advanced imaging techniques such as …
Phase: PHASE4 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:04 UTC
-
Menthol gloves may soothe nerve pain caused by chemotherapy
Symptom relief OngoingThe goal of this clinical trial is to learn if menthol works to relieve chronic neuropathic pain and chemotherapy-induced peripheral neuropathy (CIPN). The primary objectives are to evaluate the safety and clinical efficacy of menthol-containing gloves and foot-covers, specifical…
Phase: PHASE2 • Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Can a wearable sensor beat fingersticks for hospital diabetes care?
Disease control Recruiting nowThis study aims to compare inpatient glycemic control by measuring the percentage of time in the range of 70-180 mg/dl and the frequency of hypoglycemia between Dexcom G7 Continuous Glucose Monitoring (CGM) and Point of Care (POC) Blood Glucose Testing in poorly controlled subjec…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New PET scan could slash radiation by 100x
Diagnosis ENROLLING_BY_INVITATIONThe goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for Parkinsonian syndromes, neuroendocrine tumors, and gliomas detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan …
Phase: PHASE2 • Sponsor: Akiva Mintz • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New digital program helps spine surgery patients walk more
Symptom relief Recruiting nowThis study aims to investigate whether Get Back is more effective than standard rehabilitation in increasing the number of steps per day, improving physical activity levels, and functional ability for patients undergoing surgery for lumbar spinal stenosis (LSS). LSS is common, es…
Phase: NA • Sponsor: Sophiahemmet University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Smart glucose monitor plus online dietitian could transform diabetes care
Disease control OngoingA parallel, single-blinded, randomised clinical trial conducted remotely across Australia from the Mary MacKillop Institute for Health Research (MMIHR, Australian Catholic University) for individuals with type 2 diabetes, by researchers from Australian Catholic University, Univer…
Phase: NA • Sponsor: Australian Catholic University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Tailored activity plans could boost heart health in kids with congenital heart disease
Disease control CompletedCongenital heart disease (CHD) is the most common birth defect worldwide and occurs in every 8-10 per 1000 live births in Northern Ireland. The ability to participate in physical activity (PA) is an important aspect to an individual's quality of life. The UK Chief Medical Officer…
Phase: NA • Sponsor: University of Ulster • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can a smartphone app lift teen depression?
Symptom relief Recruiting nowCADS-D aimes to evaluate the effectiveness and feasibility of a newly DCBT program for Chinese adolescents with depressive symptoms.
Phase: NA • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New pill hopes to ease rare mitochondrial disease
Disease control CompletedThis is a randomized, double-blind, placebo-controlled study. Prior to treatment, patients will undergo a screening visit. If eligible, each subject will return for a Day 1 visit and will receive their first dose of investigational product (TTI-0102 or placebo). At the end of the…
Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug ZL-1310 tested in patients with Hard-to-Treat cancers
Disease control Recruiting nowA Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a phone app help save young lives? colombia tests digital suicide prevention in schools
Knowledge-focused Recruiting nowThis study will investigate a multi-level approach that applies technology-assisted methods to reduce suicidal thoughts and behaviors (SIB) and promote mental health among Colombian youth: (a) digital platform for youth; (b) digital platform for teachers; and (c) hybrid mental he…
Phase: NA • Sponsor: Brown University • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New program aims to tackle youth football concussions by training coaches
Prevention Recruiting nowHead impacts in collision sports such as football are a public health concern, as repetitive head impacts, even if a concussion is not suspected, have negative effects on brain health. This study has partnered with a community stakeholder group to create a safety program for yout…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jun 26, 2026 15:45 UTC
-
Could a milk thistle extract help Parkinson's patients?
Disease control Recruiting nowParkinson's disease (PD) is a leading neurodegenerative movement disorder, marked by a gradual loss of dopamine-producing neurons in the substantia nigra pars compacta (SNpc) and the accumulation of α-synuclein protein aggregates. Silymarin, a polyphenolic flavonoid renowned for …
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
AI could spot liver cancer early in hepatitis b patients
Knowledge-focused Recruiting nowLiver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data …
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:15 UTC
-
Liquid plug could stop bleeding without surgery
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.
Phase: NA • Sponsor: Medtronic Endovascular • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Experimental drug combo takes on advanced cancers
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of QLP2117 in combination with QL2107 in Advanced Solid Tumor Patients.
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC